KAZANCHYAN ANNA 4
4 · Foamix Pharmaceuticals Ltd. · Filed Jul 17, 2019
Insider Transaction Report
Form 4
KAZANCHYAN ANNA
Director
Transactions
- Sale
Ordinary Shares
2019-07-15$2.31/sh−808$1,866→ 44,547 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2019.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.28 to $2.33 inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.